Fig. 2
From: Inhibition of angiogenesis by platelets in systemic sclerosis patients
Antiangiogenic factors predominate in systemic sclerosis (SSc) platelet releasates. a Vascular endothelial growth factor, 165b isoform (VEGF165b), determination in platelet supernatants. We observed significantly higher levels of VEGF165b in SSc platelet supernatants (*p < 0.05, t test). b Total vascular endothelial growth factor (VEGF) was evaluated in platelet supernatants, and a relationship between VEGF165b and VEGF was established. SSc platelets releasate showed increased levels of the antiangiogenic factor VEGF165b